Skip to Content

    Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

    Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

    In the News | Alzheimer's Association

    Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

    About the Alzheimer's Association

    The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.